Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 5

1.

HIV-1 diversity after a class switch failure.

Kolber MA, Buendia P, Degruttola V, Moore RD.

AIDS Res Hum Retroviruses. 2010 Nov;26(11):1175-80. doi: 10.1089/aid.2010.0069. Epub 2010 Sep 21.

PMID:
20854203
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV.

Cruciani M, Mengoli C, Serpelloni G, Parisi SG, Malena M, Bosco O.

Cochrane Database Syst Rev. 2013 Jun 5;6:CD008270. doi: 10.1002/14651858.CD008270.pub2. Review.

PMID:
23740608
[PubMed - indexed for MEDLINE]
3.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
[PubMed - indexed for MEDLINE]
4.

NNRTI plus PI combinations in the perspective of nucleoside-sparing or nucleoside-failing antiretroviral regimens.

Joly V, Descamps D, Yeni P.

AIDS Rev. 2002 Jul-Sep;4(3):128-39. Review.

PMID:
12416447
[PubMed - indexed for MEDLINE]
5.

HIV-1 antiretroviral resistance: scientific principles and clinical applications.

Tang MW, Shafer RW.

Drugs. 2012 Jun 18;72(9):e1-25. doi: 10.2165/11633630-000000000-00000. Review.

PMID:
22686620
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk